IL18R Beta (IL18RAP) (NM_003853) Human Recombinant Protein
CAT#: TP721063L
Purified recombinant protein of Human interleukin 18 receptor accessory protein (IL18RAP)
Need it in bulk or customized? Get a free quote |
CNY 18,030.00
货期*
2周
规格
Product images
经常一起买 (1)
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293 |
Expression cDNA Clone or AA Sequence |
Phe20-Arg356
|
Tag | C-His |
Predicted MW | 39.4 kDa |
Concentration | lot specific |
Purity | Greater than 95% as determined by RP-HPLC and reducing SDS-PAGE. |
Buffer | Lyophilized from a 0.2 um filtered solution of PBS, pH 7.4. |
Storage | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
Stability | Stable for at least 6 months from date of receipt under proper storage and handling conditions. |
Endotoxin | Endotoxin level is < 0.1 ng/µg of protein (< 1 EU/µg) |
Reference Data | |
RefSeq | NP_003844 |
Locus ID | 8807 |
UniProt ID | O95256 |
Refseq Size | 2672 |
Cytogenetics | 2q12.1 |
Refseq ORF | 1797 |
Synonyms | ACPL; CD218b; CDw218b; IL-1R-7; IL-1R7; IL-1RAcPL; IL-18R-beta; IL-18RAcP; IL-18Rbeta; IL18RB |
Summary | The protein encoded by this gene is an accessory subunit of the heterodimeric receptor for interleukin 18 (IL18), a proinflammatory cytokine involved in inducing cell-mediated immunity. This protein enhances the IL18-binding activity of the IL18 receptor and plays a role in signaling by IL18. Mutations in this gene are associated with Crohn's disease and inflammatory bowel disease, and susceptibility to celiac disease and leprosy. Alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014] |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Cytokine-cytokine receptor interaction |
Documents
FAQs |
SDS |
其它IL18R Beta产品
Customer
Reviews
Loading...